HEPATIC ENCEPHALOPATHY
Clinical trials for HEPATIC ENCEPHALOPATHY explained in plain language.
Never miss a new study
Get alerted when new HEPATIC ENCEPHALOPATHY trials appear
Sign up with your email to follow new studies for HEPATIC ENCEPHALOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common gut drug clear brain fog in liver patients?
Disease control CompletedThis study tested whether nifuroxazide, a drug used for gut infections, can help treat hepatic encephalopathy—a condition where liver disease causes confusion and brain fog. Researchers gave the drug to 80 hospitalized patients with moderate to severe symptoms. The goal was to se…
Matched conditions: HEPATIC ENCEPHALOPATHY
Phase: PHASE3 • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 26, 2026 12:44 UTC
-
New sleep drug shows promise for liver patients
Symptom relief CompletedThis study tested a sleep medication called lemborexant in 82 adults with liver cirrhosis who had trouble sleeping. The drug works by blocking wakefulness signals in the brain. Researchers measured sleep quality and checked for side effects on the liver. The goal was to see if le…
Matched conditions: HEPATIC ENCEPHALOPATHY
Phase: PHASE2 • Sponsor: Indonesia University • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Your voice may reveal hidden liver risks
Knowledge-focused CompletedThis study looked at whether speech features—like how people sound and what they say—can help detect or predict confusion caused by liver disease (hepatic encephalopathy). Researchers recorded speech tasks from 251 participants with cirrhosis and tracked their thinking skills and…
Matched conditions: HEPATIC ENCEPHALOPATHY
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC